Similarly, in patients with type 2 diabetes, elevated sclerostin levels were demonstrated to be correlated with increased carotid intima-media thickness (cIMT), potentially as a protective mechanism to slow the progression of atherosclerosis [36]. The gene discussed is SOST; the disease is type 2 diabetes mellitus.